Clinical Trial

Autologous Serum Obtained by a Closed-Circuit Collection Device

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated June 10, 2025 (before its estimated June 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
Autologous serum eye drops (ASED) are an established therapy for ocular surface diseases; however, their preparation can be costly and may not be available due to the need for germ-free conditions. This pilot trial assesses the feasibility of collecting ASED in a closed-circuit system for patients with chronic ocular surface diseases.
Trial Details
NCT Number NCT07014059
Lead Sponsor GIANCARLO FATOBENE
Collaborators: JP Farma
Conditions GVHD, Meibomian Gland Dysfunction (Disorder), Stevens-Johnson Syndrome, Limbal Keratoconjunctivitis, Recurrent Erosions of Persistent Epithelial Defects, Neurotrophic Ulcer, Sjogren Syndrome With Keratoconjunctivitis
Enrollment 16 participants
Start Date 2025-06-20
Primary Completion 2026-06-20 (estimated)
Study Completion 2027-06-20 (estimated)
Updated on ClinicalTrials.gov 2025-06-10